The briefing
Researchers at Columbia University Irving Medical Center identified a gene that drives neuroendocrine prostate cancer, an especially aggressive subtype. The finding offers a potential therapeutic target pending further validation and clinical study.
Original headline
Scientists identify new therapeutic target for deadly prostate cancer